Research ArticleNuclear Oncology
Multitracer Studies During Gene Therapy of Hepatoma Cells with Herpes Simplex Virus Thymidine Kinase and Ganciclovir
Uwe Haberkorn, Annette Altmann, Iris Morr, Christine Germann, Franz Oberdorfer and Gerhard van Kaick
Journal of Nuclear Medicine July 1997, 38 (7) 1048-1054;
Uwe Haberkorn
Annette Altmann
Iris Morr
Christine Germann
Franz Oberdorfer
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Multitracer Studies During Gene Therapy of Hepatoma Cells with Herpes Simplex Virus Thymidine Kinase and Ganciclovir
Uwe Haberkorn, Annette Altmann, Iris Morr, Christine Germann, Franz Oberdorfer, Gerhard van Kaick
Journal of Nuclear Medicine Jul 1997, 38 (7) 1048-1054;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Molecular Imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for Monitoring Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Prodrug Activation Gene Therapy of Cancer
- Assessment of Treatment Response by Autoradiography with 14C-Aminocyclopentane Carboxylic Acid, 67Ga-DTPA, and 18F-FDG in a Herpes Simplex Virus Thymidine Kinase/Ganciclovir Brain Tumor Model
- Preclinical Evaluation of the Penciclovir Analog 9-(4-[18F]Fluoro-3-Hydroxymethylbutyl)Guanine for In Vivo Measurement of Suicide Gene Expression with PET
- Treatment of SW620 Cells with Tomudex and Oxaliplatin Induces Changes in 2-Deoxy-D-Glucose Incorporation Associated with Modifications in Glucose Transport